Unusual cerebellar ataxia: "worm wobble" revisited

R Shroff1, B Houston

  • 1Luton & Dunstable Hospital, Luton, UK. rcshroff@hotmail.com

Insights

A 2-year-old girl developed cerebellar ataxia after piperazine citrate treatment for worms. This case highlights delayed neurotoxicity as a potential risk of piperazine therapy in children.

Area of Science:

  • Pediatric Neurology
  • Clinical Toxicology

Background:

  • Piperazine citrate is a common anthelmintic medication used to treat parasitic worm infections.
  • Neurotoxicity is a rare but serious adverse effect associated with certain medications.

Observation:

  • A 2-year-old previously healthy female child presented with symptoms of cerebellar ataxia.
  • The onset of ataxia occurred several days after receiving piperazine citrate for suspected helminthiasis.

Findings:

  • This case represents the first documented instance of delayed-onset neurotoxicity following piperazine citrate administration.
  • Cerebellar ataxia was the primary neurological manifestation observed.

Implications:

  • Clinicians should be aware of the potential for delayed neurotoxicity with piperazine citrate, even in young children.
  • Further investigation into the mechanisms of piperazine-induced neurotoxicity may be warranted.